Trial Profile
Phase Ib Open Label, Randomized, Controlled, Dose-Escalation Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Volunteers in South Africa.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs BCG vaccine (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 18 Nov 2011 Actual end date (March 2011) added as reported by ClinicalTrials.gov.
- 18 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.